Nerbio Medical Software Platforms, Inc.

Nerbio’s iTOF® Receives FDA Clearance as First App-Controlled Neuromuscular Blockade Monitor

Nerbio Medical Software Platforms, Inc., a leader in intelligent patient monitoring solutions, proudly announces that its iTOF® device has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This milestone marks iTOF as the world’s first wireless, app-controlled quantitative neuromuscular blockade (NMB) monitoring device to achieve FDA clearance. - June 05, 2025